4-89248474-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198281.3(GPRIN3):āc.1637T>Cā(p.Val546Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000515 in 1,612,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198281.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPRIN3 | NM_198281.3 | c.1637T>C | p.Val546Ala | missense_variant | 2/2 | ENST00000609438.2 | NP_938022.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPRIN3 | ENST00000609438.2 | c.1637T>C | p.Val546Ala | missense_variant | 2/2 | 2 | NM_198281.3 | ENSP00000476603 | P1 | |
GPRIN3 | ENST00000333209.4 | c.1637T>C | p.Val546Ala | missense_variant | 1/1 | ENSP00000328672 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152026Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 249980Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135128
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1460324Hom.: 0 Cov.: 34 AF XY: 0.0000165 AC XY: 12AN XY: 726446
GnomAD4 genome AF: 0.000329 AC: 50AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.1637T>C (p.V546A) alteration is located in exon 2 (coding exon 1) of the GPRIN3 gene. This alteration results from a T to C substitution at nucleotide position 1637, causing the valine (V) at amino acid position 546 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at